Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bergemalm

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Gastroenterology|July 19, 2021
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH studyCarl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, et al.
Clinical and Experimental Gastroenterology|June 10, 2025
Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and OutcomeSimen Svendsen Vatn, Simen Hyll Hansen, Tone Møller Tannæs, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2024
Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBDMaria Ling Lundström, Christer Peterson, Charlotte R H Hedin, et al.
Journal of Crohn'S & Colitis|August 27, 2022
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating MethylomeRahul Kalla, Alex T Adams, Jan K Nowak, et al.
Clinical and Experimental Gastroenterology|August 5, 2022
Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative ColitisLuiza Moraes Holst, Jonas Halfvarson, Marie Carlson, et al.
Clinical and Experimental Gastroenterology|February 21, 2022
Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character CohortSimen Svendsen Vatn, Jonas Christoffer Lindstrøm, Aina E F Moen, et al.
Journal of Crohn'S & Colitis|January 13, 2022
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel DiseaseSimonas Juzenas, Matthias Hübenthal, Carl Mårten Lindqvist, et al.
Gastroenterology|November 28, 2024
Preclinical Protein Signatures of Crohn's Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based CohortsOlle Grännö, Daniel Bergemalm, Benita Salomon, et al.
Clinical Pharmacology and Therapeutics|February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE ExperienceJulien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.
BMJ Open|May 6, 2025
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD)Benita Salomon, Olle Grännö, Daniel Bergemalm, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Gastroenterology|July 19, 2021
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH studyCarl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, et al.
Clinical and Experimental Gastroenterology|June 10, 2025
Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and OutcomeSimen Svendsen Vatn, Simen Hyll Hansen, Tone Møller Tannæs, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2024
Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBDMaria Ling Lundström, Christer Peterson, Charlotte R H Hedin, et al.
Journal of Crohn'S & Colitis|August 27, 2022
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating MethylomeRahul Kalla, Alex T Adams, Jan K Nowak, et al.
Clinical and Experimental Gastroenterology|August 5, 2022
Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative ColitisLuiza Moraes Holst, Jonas Halfvarson, Marie Carlson, et al.
Clinical and Experimental Gastroenterology|February 21, 2022
Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character CohortSimen Svendsen Vatn, Jonas Christoffer Lindstrøm, Aina E F Moen, et al.
Journal of Crohn'S & Colitis|January 13, 2022
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel DiseaseSimonas Juzenas, Matthias Hübenthal, Carl Mårten Lindqvist, et al.
Gastroenterology|November 28, 2024
Preclinical Protein Signatures of Crohn's Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based CohortsOlle Grännö, Daniel Bergemalm, Benita Salomon, et al.
Clinical Pharmacology and Therapeutics|February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE ExperienceJulien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.
BMJ Open|May 6, 2025
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD)Benita Salomon, Olle Grännö, Daniel Bergemalm, et al.
Pageof 5